Search
Telix Pharmaceuticals Ltd
TLXAdd to Watchlist
10.090USD
+0.150+1.51%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
3.45BMarket Cap
--P/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
5
analysts
Strong Buy
Current Rating
19.416
Target Price
+95.33%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Telix Pharmaceuticals Ltd
TLX
5
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is the analyst rating for Telix Pharmaceuticals Ltd?
Based on the ratings of Telix Pharmaceuticals Ltd's stock from 5 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.
